FDA Launches Major Review of CGMPs

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-10-02-2002, Volume 26, Issue 10

FDA is set to revise CGMPs to encourage new manufacturing technologies and develop improved agency policies to ensure drug quality and safety.

Related Content:

Regulatory/GMP ComplianceRegulatory WatchPharmaceutical Technology-10-02-2002
What Does the FDA's Recent Update of the Nitrosamine Guidance Convey?
AAPS PharmSci 360 2024: How AI is Helping to Ensure Companies’ GMP Health
CPHI Milan 2024: Evolution of Aseptic Processing Equipment for Regulatory Compliance